{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T13:34:31Z","timestamp":1770471271218,"version":"3.49.0"},"reference-count":36,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Objective: Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as the most common chronic liver disease, is soon to be the leading indication for liver transplantation; however, the diagnosis may remain occult for decades. There is a need for biomarkers that identify patients at risk for MASLD and patients at risk for disease progression to optimize patient management and outcomes. Lymph node adiposity (LNA) is a novel marker of adiposity identified within axillary lymph nodes on screening mammography. Recent studies have demonstrated a correlation between LNA and cardiometabolic disease and cardiovascular disease risk. This study aimed to investigate the association between MASLD and LNA to evaluate the potential of mammographic LNA to serve as an imaging biomarker of MASLD. Methods: We identified women with pathology-proven MASLD who had a liver biopsy and a screening mammogram within 12 months of the liver biopsy. This resulted in a sample size of 161 women for final analysis that met the inclusion criteria. We evaluated lymph node adiposity through multiple measurements of the largest axillary lymph node visualized on mammography and correlated LNA with MASLD histology. Statistical analysis using univariable and multivariable logistic regression and odds ratios was performed using R version 4.1.0 (2021), the R Foundation for Statistical Computing Platform. Results: We found a significant association between MASLD and mammographic LNA, defined as lymph node (LN) length &gt; 16 mm (p = 0.0004) that remained significant after adjusting for clinical factors, including body mass index (BMI). We additionally found a significant association between LNA and metabolic dysfunction-associated steatohepatitis (MASH), identified via liver biopsy (p = 0.0048). Conclusions: Mammographic lymph node adiposity may serve as a helpful imaging biomarker of MASLD in women who have an elevated risk for the development of MASH.<\/jats:p>","DOI":"10.3390\/biomedicines13010080","type":"journal-article","created":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T14:35:42Z","timestamp":1735742142000},"page":"80","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lymph Node Adiposity and Metabolic Dysfunction-Associated Steatotic Liver Disease"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5910-0637","authenticated-orcid":false,"given":"Jessica M.","family":"Rubino","sequence":"first","affiliation":[{"name":"Radiology Department, Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie Yanzi","family":"Ring","sequence":"additional","affiliation":[{"name":"Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna","family":"Patel","sequence":"additional","affiliation":[{"name":"Hartford Healthcare, Midstate Radiology Associates, Hartford, CT 06103, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqing","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Biomedical Data Science, Dartmouth College, HB 7261, Lebanon, NH 03756, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd A.","family":"MacKenzie","sequence":"additional","affiliation":[{"name":"Department of Biomedical Data Science, Dartmouth College, HB 7261, Lebanon, NH 03756, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0589-8158","authenticated-orcid":false,"given":"Roberta M.","family":"diFlorio-Alexander","sequence":"additional","affiliation":[{"name":"Radiology Department, Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA"},{"name":"Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic Fatty Liver Disease 2020: The State of the Disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S2213-8587(22)00003-1","article-title":"A global view of the interplay between non-alcoholic fatty liver disease and diabetes","volume":"10","author":"Stefan","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep4.1018","article-title":"Nonalcoholic fatty liver disease-related cirrhosis is commonly unrecognized and associated with hepatocellular carcinoma","volume":"1","author":"Bertot","year":"2017","journal-title":"Hepatol. Commun."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/apt.16016","article-title":"Patterns and predictors of mortality and disease progression among patients with non-alcoholic fatty liver disease","volume":"52","author":"Canbay","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.amjmed.2020.01.007","article-title":"Nonalcoholic fatty liver disease: What does the primary care physician need to know?","volume":"133","author":"Budd","year":"2020","journal-title":"Am. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Powell, E.E. (2024). A new treatment and updated clinical practice guidelines for MASLD. Nat. Rev. Gastroenterol. Hepatol.","DOI":"10.1038\/s41575-024-01014-y"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cld.2017.08.003","article-title":"The Natural History of Nonalcoholic Fatty Liver Disease\u2014An Evolving View","volume":"22","author":"Lindenmeyer","year":"2018","journal-title":"Clin. Liver Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"21630","DOI":"10.1002\/jcp.28821","article-title":"Impact of different ectopic fat depots on cardiovascular and metabolic diseases","volume":"234","author":"Ferrara","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","article-title":"Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: A position statement","volume":"7","author":"Neeland","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12944-020-01288-6","article-title":"Association between nonalcoholic fatty liver disease and extrahepatic cancers: A systematic review and meta-analysis","volume":"19","author":"Liu","year":"2020","journal-title":"Lipids Health Dis."},{"key":"ref_14","first-page":"20170110","article-title":"Correlation between obesity and fat-infiltrated axillary lymph nodes visualized on mammography","volume":"91","author":"Alexander","year":"2018","journal-title":"Br. J. Radiol."},{"key":"ref_15","first-page":"99","article-title":"Effects of Obesity on Axillary Lymph Node Structure: Association of Hilar Fat Deposition and Alterations in Cortex Width","volume":"15","author":"Elham","year":"2020","journal-title":"Maedica (Bucur)"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/osp4.608","article-title":"Association between fat-infiltrated axillary lymph nodes on screening mammography and cardiometabolic disease","volume":"8","author":"Song","year":"2022","journal-title":"Obes. Sci. Pract."},{"key":"ref_17","unstructured":"Rubino, J., Austin-Strohbehn, J.A., Wang, Q., Ali, T., Tosteson, T.D., Stumez, K., and diFlorio-Alexander, R.M. (2024, December 23). Fat-Enlarged Axillary Lymph Nodes on Screening Mammograms Predict Cardiometabolic Disease and Cardiovascular Disease Risk. Available online: https:\/\/apps.arrs.org\/AbstractsAM24Open\/Main\/AwardWinningOnlinePosters."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Dwan, D., Ramin, S.K., Chen, Y., Muller, K.E., and diFlorio-Alexander, R.M. (2022). Decrease in the Size of Fat-Enlarged Axillary Lymph Nodes and Serum Lipids after Bariatric Surgery. Cells, 11.","DOI":"10.3390\/cells11030482"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10549-021-06262-z","article-title":"Fat-enlarged axillary lymph nodes are associated with node-positive breast cancer in obese patients","volume":"189","author":"Song","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.annepidem.2017.11.007","article-title":"MultIethNic Study of BrEast ARterial Calcium Gradation and CardioVAscular Disease: Cohort recruitment and baseline characteristics","volume":"28","author":"Iribarren","year":"2018","journal-title":"Ann. Epidemiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"I384","DOI":"10.1093\/jbi\/wbad042","article-title":"Screening Mammography Utilization in the United States","volume":"5","author":"Funaro","year":"2023","journal-title":"J. Breast Imaging"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3350\/cmh.2023.0035","article-title":"Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity","volume":"29","author":"Kim","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ajpath.2023.11.005","article-title":"Nonmetastatic Axillary Lymph Nodes Have Distinct Morphology and Immunophenotype in Obese Patients with Breast Cancer at Risk for Metastasis","volume":"194","author":"Song","year":"2024","journal-title":"Am. J. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Longo, M., Zatterale, F., Naderi, J., Parrillo, L., Formisano, P., Raciti, G.A., Beguinot, F., and Miele, C. (2019). Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20092358"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Verboven, K., Wouters, K., Gaens, K., Hansen, D., Bijnen, M., Wetzels, S., Stehouwer, C.D., Goossens, G.H., Schalkwijk, C.G., and Blaak, E.E. (2018). Abdominal subcutaneous and visceral adipocyte size, lipolysis and inflammation relate to insulin resistance in male obese humans. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-22962-x"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Marques, L.R., Diniz, T.A., Antunes, B.M., Rossi, F.E., Caperuto, E.C., Lira, F.S., and Gon\u00e7alves, D.C. (2018). Reverse Cholesterol Transport: Molecular Mechanisms and the Non-medical Approach to Enhance HDL Cholesterol. Front. Physiol., 9.","DOI":"10.3389\/fphys.2018.00526"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Van Herck, M.A., Weyler, J., Kwanten, W.J., Dirinck, E.L., De Winter, B.Y., Francque, S.M., and Vonghia, L. (2019). The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00082"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.3748\/wjg.v29.i32.4831","article-title":"Non-alcoholic fatty liver disease: Immunological mechanisms and current treatments","volume":"29","author":"Petagine","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","article-title":"Immune cell-mediated features of non-alcoholic steatohepatitis","volume":"22","author":"Huby","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Paquissi, F.C. (2016). Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets. Front. Immunol., 7.","DOI":"10.3389\/fimmu.2016.00490"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.plipres.2018.04.002","article-title":"STAT3: The Art of Multi-Tasking of Metabolic and Immune Functions in Obesity","volume":"70","author":"Hu","year":"2018","journal-title":"Prog. Lipid Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"a041176","DOI":"10.1101\/cshperspect.a041176","article-title":"Lymphedema and Obesity","volume":"12","author":"Sudduth","year":"2022","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41574-023-00932-2","article-title":"Emerging mechanisms of obesity-associated immune dysfunction","volume":"20","author":"Shaikh","year":"2024","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.dld.2022.02.003","article-title":"Links between Ectopic and Abdominal Fat and Systemic Inflammation: New Insights from the SHIP-Trend Study","volume":"54","author":"Hannemann","year":"2022","journal-title":"Dig. Liver Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s12325-017-0556-1","article-title":"NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk","volume":"34","author":"Ballestri","year":"2017","journal-title":"Adv. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"S588","DOI":"10.14309\/01.ajg.0000706752.88756.67","article-title":"Inflammation May Explain Gender Disparities in NAFLD and NASH","volume":"115","author":"Lessans","year":"2020","journal-title":"Am. J. Gastroenterol."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/1\/80\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T15:22:58Z","timestamp":1759850578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/1\/80"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["biomedicines13010080"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines13010080","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,1]]}}}